CANCER 2021 10.1002/cncr.33571

High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program

Park¹, S; Olsen, S; Ku, BM; Lee, MS; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ

CANCER RES TREAT 2021 10.4143/crt.2020.434

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis

Jung¹, K; Choi, JS; Koo, BM; Kim, YJ; Song, JY; Sung, M; Chang, ES; Noh, KW; An, S; Lee, MS; Song, K; Lee, H; Kim, RN; Shin, YK; Oh, DY; Choi, YL

NAT COMMUN 2020 10.1038/s41467-020-19933-0

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

Park¹, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z

J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018

Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status

Lee¹, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

J THORAC DIS 2020 10.21037/jtd-20-1716

Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma

Choi¹, Y; Kim, KH; Jeong, BH; Lee, KJ; Kim, H; Kwon, OJ; Kim, J; Choi, YL; Lee, HY; Um, SW

CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02766-7

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect

Lee¹, J; Kim, B; Jung, HA; Choi, YL; Sun, JM

THORAC CANCER 2020 10.1111/1759-7714.13648

Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma A single-institute experience of 10 cases

Cho¹, YA; Choi, YL; Hwang, I; Lee, K; Cho, JH; Han, J

J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity

Hong¹, TH; Cha, H; Shim, JH; Lee, B; Chung, J; Lee, C; Kim, NKD; Choi, YL; Hwang, S; Lee, Y; Park, S; Jung, HA; Kim, JY; Park, YH; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH; Park, WY

J TRANSL MED 2020 10.1186/s12967-020-02473-y

PDX models of human lung squamous cell carcinoma consideration of factors in preclinical and co-clinical applications

Jung¹, HY; Kim, TH; Lee, JE; Kim, HK; Cho, JH; Choi, YS; Shin, S; Lee, SH; Rhee, H; Lee, HK; Choi, HJ; Jang, HY; Lee, S; Kang, JH; Choi, YA; Lee, S; Lee, J; Choi, YL; Kim, J

ISCIENCE 2020 10.1016/j.isci.2020.101386

Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma

Kim¹, HK; Joung, JG; Choi, YL; Lee, SH; Park, BJ; Choi, YS; Ryu, D; Nam, JY; Lee, MS; Park, WY; Hwang, S; Cha, H; Kim, HS; Lee, S; Jung, Y; Lee, JE; Doh, J; Paik, S; Kang, JH; Lee, J; Kim, J

GENOME BIOL 2020 10.1186/s13059-020-02076-2

Dysregulation of cancer genes by recurrent intergenic fusions

Yun¹, JW; Yang, LX; Park, HY; Lee, CW; Cha, HG; Shin, HT; Noh, KW; Choi, YL; Park, WY; Park, PJ

ANN ONCOL 2020 10.1016/j.annonc.2020.04.004

HLA-corrected tumor mutation burden and homologous recombination de fi ciency for the prediction of response to PD -(L)1 blockade in advanced non -small -cell lung cancer patients

Shim¹, JH; Kim, HS; Cha, H; Kim, S; Kim, TM; Anagnostou, V; Choi, YL; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Park, WY; Lee, SH

EUR J CANCER 2020 10.1016/j.ejca.2020.03.029

Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma

Lee¹, J; La Choi, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

CLIN LUNG CANCER 2020 10.1016/j.cllc.2019.11.006

Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests

Byeon¹, S; Lee, B; Park, WY; Choi, YL; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH

NAT COMMUN 2020 10.1038/s41467-020-16164-1

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Kim¹, N; Kim, HK; Lee, K; Hong, Y; Cho, JH; Choi, JW; Lee, J; Suh, YL; Ku, BM; Eum, HH; Choi, S; Choi, YL; Joung, JG; Park, WY; Jung, HA; Sun, JM; Lee, SN; Ahn, JS; Park, K; Ahn, MJ; Lee, HO

J MOL DIAGN 2020 10.1016/j.jmoldx.2019.10.015

Junction Location Identifier (JuLI) Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology

Shin¹, HT; Kim, NKD; Yun, JW; Lee, B; Kyung, S; Lee, KW; Ryu, D; Kim, J; Bae, JS; Park, D; Choi, YL; Lee, SH; Ahn, MJ; Park, K; Park, WY

MOL THER-ONCOLYTICS 2020 10.1016/j.omto.2019.12.009

IRS2 Amplification as a Predictive Biomarker in Response to Ceritinib in Small Cell Lung Cancer

Lee¹, MS; Jung, K; Song, JY; Sung, MJ; Ahn, SB; Lee, B; Oh, DY; Choi, YL

Front Oncol 2020 10.3389/fonc.2019.01574

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer

Kim¹, YJ; Lee, GH; Han, JN; Song, K; Choi, JS; Choi, YL; Shin, YK

BIOMOLECULES 2020 10.3390/biom10010051

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting

Yang¹, H; Park, H; Lee, YJ; Choi, JY; Kim, T; Rajasekaran, N; Lee, S; Song, K; Hong, S; Choi, JS; Shim, H; Kim, YD; Hwang, S; Choi, YL; Shin, YK

BREAST CANCER RES 2019 10.1186/s13058-019-1197-x

High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy

Na¹, H; Han, J; Ka, NL; Lee, MH; Choi, YL; Shin, YK; Lee, MO

J GASTROEN HEPATOL 2019 10.1111/jgh.14915

Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma

Min¹, BH; Yang, JW; Min, YW; Baek, SY; Kim, S; Kim, HK; Choi, YS; Shim, YM; Choi, YL; Zo, JI

EUR J CANCER 2019 10.1016/j.ejca.2019.08.001

Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing

Kim¹, HS; Cha, H; Kim, JH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH

J CLIN MED 2019 10.3390/ijms20194794

Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation

Lee¹, SE; Kim, YJ; Sung, M; Lee, MS; Han, J; Kim, HK; Choi, YL

J MOL MED-JMM 2019 10.1007/s00109-019-01815-8

Molecular changes in solitary fibrous tumor progression

Park¹, HK; Yu, DB; Sung, MJ; Oh, E; Kim, M; Song, JY; Lee, MS; Jung, K; Noh, KW; An, S; Song, K; Nam, DH; Kim, YJ; Choi, YL

EUR RADIOL 2019 10.1007/s00330-019-06445-9

Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index

Lee¹, JH; Yoon, YC; Seo, SW; Choi, YL; Kim, HS

LAB INVEST 2019 10.1038/s41374-019-0263-4

Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology

Kim¹, YJ; Kim, M; Park, HK; Yu, DB; Jung, K; Song, K; Choi, YL

J PLAST RECONSTR AES 2019 10.1016/j.bjps.2019.05.021

Capsule biopsy of acellular dermal matrix (ADM) to predict future capsular contracture in two-stage prosthetic breast reconstruction

Kim¹, A; Jung, JH; Choi, YL; Pyon, JK

CANCER SCI 2019 10.1111/cas.14036

Adipogenesis induces growth inhibition of dedifferentiated liposarcoma

Kim¹, YJ; Yu, DB; Kim, M; Choi, YL

LUNG CANCER 2019 10.1016/j.lungcan.2019.05.024

Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma

Park¹, S; Shim, JH; Lee, B; Cho, I; Park, WY; Kim, Y; Lee, SH; Choi, YL; Han, J; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

J CLIN ONCOL 2019 10.1200/JCO.2017.77.3184

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

Cho¹, J; Kim, HS; Ku, BM; Choi, YL; Cristescu, R; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152441

Histopathologic characteristics of advanced-stage ROS1-rearranged non-small-cell lung cancers

Park¹, E; Choi, YL; Ahn, MJ; Han, J

Front Oncol 2019 10.3389/fonc.2019.00667

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Kwon¹, MJ; Lee, JE; Jeong, J; Woo, SU; Han, J; Kang, BI; Kim, JE; Moon, Y; Lee, SB; Lee, S; Choi, YL; Kwon, Y; Song, K; Gong, G; Shin, YK

MOL ONCOL 2019 10.1002/1878-0261.12478

Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma

Yu¹, N; Yong, S; Kim, HK; Choi, YL; Jung, Y; Kim, D; Seo, J; Lee, YE; Baek, D; Lee, J; Lee, S; Lee, JE; Kim, J; Kim, J; Lee, S

CLIN LUNG CANCER 2019 10.1016/j.cllc.2018.12.020

Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor

Lee¹, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ

J IMMUNOTHER CANCER 2019 10.1186/s40425-019-0609-x

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

Park¹, S; Joung, JG; Min, YW; Nam, JY; Ryu, D; Oh, D; Park, WY; Lee, SH; Choi, YL; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

CLIN LUNG CANCER 2019 10.1016/j.cllc.2018.12.021

Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients

Da Nam¹, B; Kim, TJ; Park, K; Ahn, MJ; Choi, YL; Chung, MJ; Kim, TS; Lee, KS

BMC CANCER 2019 10.1186/s12885-019-5713-2

Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

Jo¹, EB; Lee, YS; Lee, H; Park, JB; Park, H; Choi, YL; Hong, D; Kim, SJ

CANCER RES TREAT 2019 10.4143/crt.2018.125

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Park¹, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

CANCER RES TREAT 2019 10.4143/crt.2018.151

Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea

Byeon¹, S; Kim, Y; Lim, SW; Cho, JH; Park, S; Lee, J; Sun, JM; Choi, YL; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

LUNG CANCER 2019 10.1016/j.lungcan.2019.01.012

Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer

Lee¹, K; Kim, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Choi, YL; Sun, JM

J THORAC ONCOL 2019 10.1016/j.jtho.2018.10.150

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Kim¹, Y; Lee, B; Shim, JH; Lee, SH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K

J TRANSL MED 2018 10.1186/s12967-018-1658-5

Status of programmed death-ligand 1 expression in sarcomas

Park¹, HK; Kim, M; Sung, M; Lee, SE; Kim, YJ; Choi, YL

ASIA-PAC J CLIN ONCO 2018 10.1111/ajco.12769

Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma

Cho¹, CW; Lee, KW; Park, H; Kim, HJ; Park, JB; Choi, YL; Yu, JI; Lee, SJ; Choi, DI; Kim, SJ

J THORAC ONCOL 2018 10.1016/j.jtho.2018.05.026

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice

Park¹, S; Ahn, BC; Lim, SW; Sun, JM; Kim, HR; Hong, MH; Lee, SH; Ahn, JS; Park, K; La Choi, Y; Cho, BC; Ahn, MJ

CLIN CANCER RES 2018 10.1158/1078-0432.CCR-17-3492

Integrin beta 3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC

Noh¹, KW; Sohn, I; Song, JY; Shin, HT; Kim, YJ; Jung, K; Sung, M; Kim, M; An, S; Han, J; Lee, SH; Lee, MS; Choi, YL

LUNG CANCER 2018 10.1016/j.lungcan.2018.06.009

Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma

Lee¹, J; Jung, HA; Kim, Y; Choi, S; Han, J; Choi, YL; Lee, SH; Ahn, JS; Park, K; Sun, JM

SCI REP-UK 2018 10.1038/s41598-018-25800-2

Genomic alterations of ground-glass nodular lung adenocarcinoma

Lee¹, H; Joung, JG; Shin, HT; Kim, DH; Kim, Y; Kim, H; Kwon, OJ; Shim, YM; Lee, HY; Lee, KS; Choi, YL; Park, WY; Hayes, DN; Um, SW

CANCER BIOL THER 2018 10.1080/15384047.2018.1423913

Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer

Kim¹, YJ; Sung, M; Oh, E; Vrancken, MV; Song, JY; Jung, K; Choi, YL

J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e123

Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors

Sim¹, J; Kim, H; Hyeon, J; Choi, YL; Han, J

NAT COMMUN 2018 10.1038/s41467-018-04129-4

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Kan¹, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH

WORLD J SURG 2018 10.1007/s00268-017-4157-6

Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival

Rhu¹, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, YL; Kim, SJ

SCI REP-UK 2018 10.1038/s41598-017-18642-x

Droplet digital PCR-based &ITEGFR &ITmutation detection with an internal quality control index to determine the quality of DNA

Kim¹, SS; Choi, HJ; Kim, JJ; Kim, MS; Lee, IS; Byun, B; Jia, LN; Oh, MR; Moon, Y; Parka, S; Choi, JS; Chae, SW; Nam, BH; Kim, JS; Kim, J; Min, BS; Lee, JS; Won, JK; Cho, S; Choi, YL; Shin, YK

CANCER RES TREAT 2018 10.4143/crt.2016.591

Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer

Cho¹, JH; Zhou, W; Choi, YL; Sun, JM; Choi, H; Kim, TE; Dolled-Filhart, M; Emancipator, K; Rutkowski, MA; Kim, J

CAN J SURG 2017 10.1503/cjs.005917

Comparison of retroperitoneal liposarcoma extending into the inguinal canal and inguinoscrotal liposarcoma

Rhu¹, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, Y; Kim, SJ

NAT COMMUN 2017 10.1038/s41467-017-01470-y

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

Shin¹, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY

CLIN LUNG CANCER 2017 10.1016/j.cllc.2017.04.008

Programmed Death Ligand 1 Expression in Paired Non-Small-Cell Lung Cancer Tumor Samples

Cho¹, JH; Sorensen, SF; Choi, YL; Feng, Y; Kim, TE; Choi, H; Georgsen, JB; Dolled-Filhart, M; Emancipator, K; Meldgaard, P; Sun, JM; Kim, HK; Choi, YS; Shim, YM; Zhou, W; Hager, H; Kim, J

J PATHOL 2017 10.1002/path.4950

Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer

Noh¹, KW; Lee, MS; Lee, SE; Song, JY; Shin, HT; Kim, YJ; Oh, DY; Jung, K; Sung, M; Kim, M; An, S; Han, J; Shim, YM; Zo, JI; Kim, J; Park, WY; Lee, SH; Choi, YL

ONCOTARGET 2017 10.18632/oncotarget.21150

Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer

Kwon¹, MJ; Kim, RN; Song, K; Jeon, S; Jeong, HM; Kim, JS; Han, J; Hong, S; Oh, E; Choi, JS; An, J; Pollack, JR; Choi, YL; Park, CK; Shin, YK

CANCER RES TREAT 2017 10.4143/crt.2016.322

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies

Heo¹, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW

PATHOLOGY 2017 10.1016/j.pathol.2017.05.010

Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer

Choi¹, JS; Kim, KH; Oh, E; Shin, YK; Seo, J; Kim, SH; Park, S; Choi, YL

CANCER RES TREAT 2017 10.4143/crt.2016.347

Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients

Lee¹, MS; Jung, EA; An, SB; Kim, YJ; Oh, DY; Song, JY; Um, SW; Han, J; Choi, YL

Neoplasia 2017 10.1016/j.neo.2017.07.005

Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions

Rajasekaran¹, N; Jung, HS; Bae, SH; Chelakkot, C; Hong, S; Choi, JS; Yim, DS; Oh, YK; Choi, YL; Shin, YK

Oncogenesis 2017 10.1038/oncsis.2017.87

ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells

Jeong¹, HM; Han, J; Lee, SH; Park, HJ; Lee, HJ; Choi, S; Lee, YM; Choi, YL; Shin, YK; Kwon, MJ

PLoS One 2017 10.1371/journal.pone.0185826

Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans

Oh¹, E; Jeong, HM; Kwon, MJ; Ha, SY; Park, HK; Song, JY; Kim, YJ; Choi, JS; Lee, EH; Lee, J; Choi, YL; Shin, YK

CYTOTHERAPY 2017 10.1016/j.jcyt.2017.05.008

Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus-thymidine kinase-expressing mesenchymal stromal cells

Lee¹, H; Jo, EB; Kim, SJ; Yang, HM; Kim, YM; Sung, YC; Park, JB; Hong, D; Park, H; Choi, YL; Kim, SJ

ONCOTARGET 2017 10.18632/oncotarget.18618

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients

Jeong¹, HM; Kim, RN; Kwon, MJ; Oh, E; Han, J; Lee, SK; Choi, JS; Park, S; Nam, SJ; Gong, GY; Nam, JW; Choi, DH; Lee, H; Nam, BH; Choi, YL; Shin, YK

BMC CANCER 2017 10.1186/s12885-017-3525-9

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Oh¹, DY; Jung, K; Song, JY; Kim, S; Shin, S; Kwon, YJ; Oh, E; Park, WY; Song, SY; Choi, YL

J THORAC ONCOL 2017 10.1016/j.jtho.2017.04.031

MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values

Lee¹, GD; Lee, SE; Oh, DY; Yu, DB; Jeong, HM; Kim, J; Hong, S; Jung, HS; Oh, E; Song, JY; Lee, MS; Kim, M; Jung, K; Kim, J; Shin, YK; Choi, YL; Kim, HR

MEDICINE 2017 10.1097/MD.0000000000007537

Single-center experience with intra-abdominal liposarcoma Optimal minimum duration for postoperative remnant tumor screening

Rhu¹, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, YL; Kim, SJ

J CLIN ONCOL 2017 10.1200/JCO.2016.71.3701

Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement

Lim¹, SM; Kim, HR; Lee, JS; Lee, KH; Lee, YG; JooMin, Y; Cho, EK; Lee, SS; Kim, BS; Choi, MY; Shim, HS; Chung, JH; La Choi, Y; Lee, MJ; Kim, M; Kim, JH; Ali, SM; Ahn, MJ; Cho, BC

CLIN RADIOL 2017 10.1016/j.crad.2017.02.003

Diagnostic performance of conventional MRI parameters and apparent diffusion coefficient values in differentiating between benign and malignant soft-tissue tumours

Song¹, Y; Yoon, YC; Chong, Y; Seo, SW; Choi, YL; Sohn, I; Kim, MJ

LUNG CANCER 2017 10.1016/j.lungcan.2017.04.009

Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq

Zhang¹, L; Li, SY; Choi, YL; Lee, J; Gong, ZL; Liu, XQ; Pei, YF; Jiang, AW; Ye, MZ; Mao, M; Zhang, XG; Kim, J; Chen, RH

WORLD J SURG 2017 10.1007/s00268-017-3908-8

Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma

Kim¹, KW; Kim, HK; Kim, J; Shim, YM; Ahn, MJ; Choi, YL

BREAST CANCER RES TR 2017 10.1007/s10549-017-4234-4

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer

Han¹, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK

PATHOL RES PRACT 2017 10.1016/j.prp.2017.02.021

Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine

Yang¹, JW; Choi, YL

Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9.

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer

Jang HJ1¹,2,3, Lee HS1,2,4,5, Burt BM4, Lee GK5, Yoon KA5,6, Park YY2, Sohn BH2, Kim SB2, Kim MS1, Lee JM1, Joo J7, Kim SC8, Yun JS9, Na KJ9, Choi YL10, Park JL11, Kim SY11, Lee YS12, Han L13,14, Liang H13, Mak D15, Burks JK15, Zo JI16, Sugarbaker DJ4, Shim YM16, Lee JS2.

Ann Oncol. 2017 Feb 1;28(2):292-297. doi: 10.1093/annonc/mdw559.

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Lee SH1¹, Lee JK2, Ahn MJ1, Kim DW2, Sun JM1, Keam B2, Kim TM2, Heo DS2, Ahn JS1, Choi YL3, Min HS4, Jeon YK4, Park K1.

Oncotarget. 2017 Jan 10;8(2):3519-3527. doi: 10.18632/oncotarget.13864.

KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma

Park JK1¹, Lee YJ1, Lee JK1, Lee KT1, Choi YL2, Lee KH1,3.

Lung Cancer. 2016 Apr;94:22-7. doi: 10.1016/j.lungcan.2016.01.011. Epub 2016 Jan 21.

ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare

Zhao W1¹, Choi YL2, Song JY3, Zhu Y4, Xu Q1, Zhang F1, Jiang L1, Cheng J1, Zheng G5, Mao M6.

J Thorac Oncol. 2016 Dec;11(12):2129-2140. doi: 10.1016/j.jtho.2016.08.142. Epub 2016 Sep 9.

Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma

Li S1¹, Choi YL2, Gong Z1, Liu X1, Lira M3, Kan Z3, Oh E2, Wang J4, Ting JC4, Ye X4, Reinhart C4, Liu X5, Pei Y5, Zhou W5, Chen R5, Fu S6, Jin G6, Jiang A1, Fernandez J3, Hardwick J3, Kang MW7, I H8, Zheng H1, Kim J2, Mao M9.

Oncotarget. 2016 Dec 13;7(50):82876-82888. doi: 10.18632/oncotarget.12657.

LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Kim YJ1¹, Hong S2, Sung M1, Park MJ2, Jung K1,3, Noh KW1,3, Oh DY1,3, Lee MS1,3, Oh E1,3, Shin YK2,4, Choi YL1,3,5.

Intern Med. 2016;55(21):3105-3111. Epub 2016 Nov 1.

Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Lee K1¹, Um SW, Jeong BH, Yang JW, Choi YL, Han J, Kim H, Kwon OJ.

J Thorac Dis. 2016 Nov;8(11):3175-3186. doi: 10.21037/jtd.2016.11.25.

The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations

Cha YK1¹, Lee HY2, Ahn MJ3, Park K3, Ahn JS3, Sun JM3, Choi YL4, Lee KS2.

Cancer. 2016 Oct;122(19):3024-31. doi: 10.1002/cncr.30135. Epub 2016 Jun 17.

Efficacy and Safety of Dovitinib in Pretreated Patients With Advanced Squamous Non-Small Cell Lung Cancer With FGFR1 Amplification: A Single-Arm, Phase 2 Study

Lim SH1¹, Sun JM1, Choi YL2, Kim HR3, Ahn S2, Lee JY1, Lee SH1, Ahn JS1, Park K1, Kim JH3, Cho BC4, Ahn MJ5.

Oncotarget. 2016 Oct 11;7(41):67302-67313. doi: 10.18632/oncotarget.11693.

Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma

Choi ER1¹, Lee HY1, Jeong JY2, Choi YL3, Kim J4, Bae J1, Lee KS1, Shim YM4.

Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26.

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Lim SH1¹, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.

CANCER RESEARCH AND TREATMENT, JAN 2016, 48(1):398-402, DOI: 10.4143/crt.2014.254

SEC31A-ALKFusion Gene in Lung Adenocarcinoma

Kim RN¹, Choi YL, Lee MS, Lira ME, Mao M, Mann D, Stahl J, Licon A, Choi SJ, Van Vrancken, M

J Appl Clin Med Phys. 2016 Sep;17(5):1-10. doi: 10.1120/jacmp.v17i5.6314.

Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model

Moon J1¹,2, Kim JH1, Choi D1, Yang J3, Lee MW1, Choi YL4, Rhim Md H1.

Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445.

Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy

Yu JI1¹, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.

Epigenomics. 2016 Aug;8(8):1061-77. doi: 10.2217/epi-2016-0038. Epub 2016 Jun 8.

Efficiency of methylated DNA immunoprecipitation bisulphite sequencing for whole-genome DNA methylation analysis

Jeong HM1¹, Lee S2, Chae H3, Kim R1,4, Kwon MJ5,6, Oh E7,8, Choi YL7,8,9, Kim S10,11,12, Shin YK1,4,12,13,14.

Medicine (Baltimore). 2016 Aug;95(32):e4435. doi: 10.1097/MD.0000000000004435.

Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control

Park H1¹, Lee S, Kim B, Lim do H, Choi YL, Choi GS, Kim JM, Park JB, Kwon CH, Joh JW, Kim SJ.

J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15.

Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion

Sung JY1¹, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.

J Thorac Oncol. 2016 Jul;11(7):1003-11. doi: 10.1016/j.jtho.2016.04.007. Epub 2016 Apr 18.

Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases

Sun JM1¹, Zhou W2, Choi YL1, Choi SJ1, Kim SE1, Wang Z2, Dolled-Filhart M2, Emancipator K2, Wu D2, Weiner R2, Frisman D3, Kim HK1, Choi YS1, Shim YM1, Kim J4.

Thyroid. 2016 Jul;26(7):901-10. doi: 10.1089/thy.2015.0488. Epub 2016 Jun 6.

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population

Lee SE1¹, Hwang TS1, Choi YL2, Han HS1, Kim WS1, Jang MH1, Kim SK3, Yang JH4.

Oncotarget. 2016 Jun 14;7(24):36101-36114. doi: 10.18632/oncotarget.9137.

Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma

Lee MS1¹,2, Kim RN3,4, I H5,6, Oh DY1,2, Song JY2, Noh KW1,2, Kim YJ1,2, Yang JW7, Lira ME8, Lee CH9, Lee MK10, Kim YD5, Mao M8,11, Han J12, Kim J13, Choi YL1,2,12.

Annu Rev Pathol. 2016 May 23;11:283-312. doi: 10.1146/annurev-pathol-012615-044446. Epub 2016 Feb 22.

Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies

Lee JK1¹, Choi YL2,3, Kwon M4,5, Park PJ6.

Am J Hum Genet. 2016 May 5;98(5):843-56. doi: 10.1016/j.ajhg.2016.03.017.

Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing

Yang L1¹, Lee MS2, Lu H3, Oh DY2, Kim YJ4, Park D4, Park G5, Ren X6, Bristow CA7, Haseley PS8, Lee S1, Pantazi A9, Kucherlapati R10, Park WY11, Scott KL3, Choi YL12, Park PJ13.

Oncotarget. 2016 May 24;7(21):30691-701. doi: 10.18632/oncotarget.8749.

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma

Kim HS1¹, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Shim YM8, Jewell SS9, Kim H3, Choi YL10, Cho BC1.

Oncotarget. 2016 Apr 26;7(17):24141-53. doi: 10.18632/oncotarget.8234.

Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma

Lee SE1¹, Oh E2,3, Lee B4, Kim YJ2, Oh DY2,3, Jung K2,3, Choi JS5, Kim J6, Kim SJ6, Yang JW7, An J8, Oh YL4, Choi YL4,2,3.

Oncotarget. 2016 Apr 26;7(17):23874-84. doi: 10.18632/oncotarget.8074.

Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers

Lee B1¹,2, Lee T1, Lee SH3,2, Choi YL1,2, Han J1.

Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318.

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation

Kim N1¹,2, Cho A2, Watanabe H3,4, Choi YL2,5, Aziz M6, Kassner M6, Joung JG7, Park AK1,2, Francis JM8, Bae JS7, Ahn SM5, Kim KM5, Park JO9, Park WY2,7, Ahn MJ9, Park K9, Koo J10, Yin HH6, Cho J1,2,7.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9(3):4123-4128

SPOP mutation in prostate cancers in Korean population: variation in its mutation frequency among ethnic groups

Yoon N¹, Sung JY, Kang SY, Kwon GY, Choi YL

J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6.

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04

Ahn JS1¹, Ahn YC1, Kim JH1, Lee CG1, Cho EK1, Lee KC1, Chen M1, Kim DW1, Kim HK1, Min YJ1, Kang JH1, Choi JH1, Kim SW1, Zhu G1, Wu YL1, Kim SR1, Lee KH1, Song HS1, Choi YL1, Sun JM1, Jung SH1, Ahn MJ1, Park K2.

BMC Cancer. 2015 Mar 19;15:154. doi: 10.1186/s12885-015-1160-x.

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

Yoo KH1¹, Kim HS2, Lee SJ3, Park SH4, Kim SJ5, Kim SH6, La Choi Y7, Shin KH8, Cho YJ9, Lee J10, Rha SY11.

Oncotarget. 2015 Dec 8;6(39):41916-28. doi: 10.18632/oncotarget.6019.

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma

Kwon OS1¹, Oh E2, Park JR1, Lee JS1, Bae GY1, Koo JH3, Kim H4, Choi YL5, Choi YS6, Kim J6, Cha HJ1.

PLoS One. 2015 Dec 7;10(12):e0144162. doi: 10.1371/journal.pone.0144162. eCollection 2015.

Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples

Oh E1¹,2,3, Choi YL1,2,4,5, Kwon MJ6,7, Kim RN3, Kim YJ1,2, Song JY1,2, Jung KS1,5, Shin YK3.

Ann Surg. 2015 Dec;262(6):965-71. doi: 10.1097/SLA.0000000000001039.

New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma

Lee GD1¹, Lee SE, Kim KM, Kim YH, Ahn JH, Jung S, Choi YL, Kim HR, Park SI, Shim YM.

Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283.

HER2 as a novel therapeutic target for cervical cancer

Oh DY1¹,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.

Oncotarget. 2015 Oct 13;6(31):32027-38. doi: 10.18632/oncotarget.5184.

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer

Park YH1¹,2, Shin HT3, Jung HH2, Choi YL3, Ahn T3, Park K3, Lee A4, Do IG5, Kim JY1,2, Ahn JS1, Park WY3, Im YH1,2.

PLoS One. 2015 Oct 7;10(10):e0139112. doi: 10.1371/journal.pone.0139112. eCollection 2015.

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer

Kwon MJ1¹, Han J2, Seo JH3, Song K4, Jeong HM3, Choi JS5, Kim YJ6, Lee SH7, Choi YL8, Shin YK9.

Medicine (Baltimore). 2015 Oct;94(41):e1753. doi: 10.1097/MD.0000000000001753.

Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach

Yoon HJ1¹, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J.

Clin Nucl Med. 2015 Jan;40(1):e34-9. doi: 10.1097/RLU.0000000000000581.

Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma

Jeong CJ1¹, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY.

J Clin Neurosci. 2015 Sep;22(9):1425-9. doi: 10.1016/j.jocn.2015.02.036. Epub 2015 Jun 29.

Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide

Kong DS1¹, Kim HR2, Choi YR3, Seol HJ1, Lee JI1, Nam DH4.

Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9722-7. doi: 10.1073/pnas.1423827112. Epub 2015 Jul 7.

Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia

Cha JY1¹, Wee J2, Jung J3, Jang Y3, Lee B2, Hong GS2, Chang BC4, Choi YL5, Shin YK6, Min HY6, Lee HY6, Na TY6, Lee MO6, Oh U7.

Diagn Cytopathol. 2015 Jul;43(7):539-44. doi: 10.1002/dc.23242. Epub 2014 Nov 26.

Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations

Song DH1¹, Lee B1, Shin Y1, Choi IH1, Ha SY1, Lee JJ1, Hong ME1, Choi YL1, Han J1, Um SW2.

Int J Mol Sci. 2015 May 29;16(6):12243-60. doi: 10.3390/ijms160612243.

Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo

Jung HS1¹,2, Rajasekaran N3, Song SY4, Kim YD5, Hong S6, Choi HJ7, Kim YS8, Choi JS9, Choi YL10, Shin YK11,12,13.

Int J Rheum Dis. 2015 Jun;18(5):514-23. doi: 10.1111/1756-185X.12501. Epub 2014 Dec 20.

A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model

Lee J1¹, Hong EC2, Jeong H1, Hwang JW1, Kim H1, Bae EK2, Ahn JK3, Choi YL4, Han J4, Cha HS1, Koh EM1.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1229-36. doi: 10.1007/s00280-015-2740-9. Epub 2015 Apr 23.

A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test

Choi MK1¹, Hong JY, Chang WJ, Kim MJ, Kim SM, Jung HA, Do IG, Choi YL, Sun JM, Ahn JS, Park K, Ahn MJ.

Head Neck. 2015 May;37(5):E66-9. doi: 10.1002/hed.23884. Epub 2015 Mar 29.

Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series

Kim SM1¹, Kim MJ, Jung HA, Sun JM, Choi YL, Ko YH, Park K, Baek CH, Son YI, Ahn MJ.

Clin Lung Cancer. 2015 May;16(3):228-36. doi: 10.1016/j.cllc.2014.11.002. Epub 2014 Nov 18.

Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Cha YK1¹, Lee HY2, Ahn MJ3, Choi YL4, Lee JH1, Park K3, Lee KS1.

Mod Pathol. 2015 Apr;28(4):468-79. doi: 10.1038/modpathol.2014.107. Epub 2014 Sep 19.

Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma

Lee SE1¹, Lee B1, Hong M1, Song JY2, Jung K3, Lira ME4, Mao M4, Han J1, Kim J5, Choi YL6.

Ann Dermatol. 2015 Apr;27(2):157-62. doi: 10.5021/ad.2015.27.2.157. Epub 2015 Mar 24.

Identification of Leukocyte-Specific Protein 1-Positive Cells: A Clue to the Cell of Origin and a Marker for the Diagnosis of Dermatofibroma

Jin SY1¹, Choi JS2, Choi YL3, Choi YL3, Kim do H1, Lee SH1.

Pancreas. 2015 Apr;44(3):484-92. doi: 10.1097/MPA.0000000000000280.

Low Frequency of KRAS Mutation in Pancreatic Ductal Adenocarcinomas in Korean Patients and Its Prognostic Value

Kwon MJ1¹, Jeon JY, Park HR, Nam ES, Cho SJ, Shin HS, Kwon JH, Kim JS, Han B, Kim DH, Choi YL.

Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30.

Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy

Lee HW1¹, Lee JI2, Lee SJ3, Cho HJ2, Song HJ4, Jeong da E5, Seo YJ2, Shin S5, Joung JG6, Kwon YJ7, Choi YL8, Park WY9, Lee HM10, Seol HJ2, Shim YM11, Joo KM12, Nam DH13.

Oncotarget. 2015 Mar 10;6(7):5465-74.

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR

Ha SY1¹, Choi SJ2, Cho JH3, Choi HJ2, Lee J2, Jung K4, Irwin D5, Liu X6,7, Lira ME8, Mao M9, Kim HK3, Choi YS3, Shim YM3, Park WY10, Choi YL1,4,10, Kim J2,3.

Oncotarget. 2015 Feb 10;6(4):2562-72.

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma

Kim HS1¹, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Jung da H7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Moon YW1, Kim JH1, Shim YM8, Jewell SS9, Kim H3, Choi YL2, Cho BC1.

Ann Oncol. 2015 Jan;26(1):161-6. doi: 10.1093/annonc/mdu504. Epub 2014 Oct 29.

Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing

Sun JM1¹, Choi YL2, Ji JH3, Ahn JS1, Kim KM2, Han J2, Ahn MJ1, Park K4.

Korean J Radiol. 2014 Sep-Oct;15(5):646-50. doi: 10.3348/kjr.2014.15.5.646. Epub 2014 Sep 12.

Synchronous Triple Primary Lung Cancers: A Case Report

Yoon HJ1¹, Lee HY1, Han J2, Choi YL2.

Oncology. 2014;86(3):159-69. doi: 10.1159/000358064. Epub 2014 Mar 12.

Low Expression of Transforming Growth Factor Beta-1 in Cancer Tissue Predicts a Poor Prognosis for Patients with Stage III Rectal Cancers

Chun HK1¹, Jung KU, Choi YL, Hong HK, Kim SH, Yun SH, Kim HC, Lee WY, Cho YB.

Skeletal Radiol. 2014 May;43(5):641-8. doi: 10.1007/s00256-014-1832-7. Epub 2014 Feb 15.

Prognostic value of F-18-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters

Hong SP1¹, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH, Choi JY.

J Surg Res. 2014 Apr;187(2):502-9. doi: 10.1016/j.jss.2013.11.010. Epub 2013 Nov 15.

Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors

Cho YB1¹, Hong HK1, Choi YL2, Oh E2, Joo KM3, Jin J4, Nam DH4, Ko YH2, Lee WY5.

Lung Cancer. 2014 Mar;83(3):411-5. doi: 10.1016/j.lungcan.2013.12.015. Epub 2014 Jan 7.

Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement

Ha SY1¹, Choi IH1, Han J2, Choi YL1, Cho JH3, Lee KJ4, Sun JM5.

J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.

Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

Lee JH1¹, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

AJR Am J Roentgenol. 2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819.

Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management

Lee HY1¹, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW.

Lung Cancer. 2014 Feb;83(2):259-64. doi: 10.1016/j.lungcan.2013.11.009. Epub 2013 Nov 20.

Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma

Sun JM1¹, Lira M2, Pandya K2, Choi YL3, Ahn JS1, Mao M2, Han J3, Park K1, Ahn MJ4, Kim J5.

PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014.

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy

Chong Y1¹, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.

Exp Mol Pathol. 2014 Dec;97(3):440-4. doi: 10.1016/j.yexmp.2014.09.013. Epub 2014 Oct 1.

The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex

Yang HM1¹, Choi HJ1, Hong DP1, Joo SY2, Lee NE2, Song JY3, Choi YL4, Lee J5, Choi D6, Kim B7, Park HJ8, Park JB9, Kim SJ10.

Mol Cancer Res. 2014 Dec;12(12):1779-95. doi: 10.1158/1541-7786.MCR-14-0191. Epub 2014 Jul 24.

SMAD4 Suppresses AURKA-Induced Metastatic Phenotypes via Degradation of AURKA in a TGF beta-Independent Manner

Jia L1¹, Lee HS2, Wu CF1, Kundu J3, Park SG4, Kim RN5, Wang LH1, Erkin ?C6, Choi JS7, Chae SW8, Yang HB2, Choi YL9, Shin YK10.

Mol Cancer Ther. 2014 Nov;13(11):2527-36. doi: 10.1158/1535-7163.MCT-14-0255. Epub 2014 Sep 23.

Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification

Kim ST1¹, Jang HL2, Lee SJ1, Lee J1, Choi YL3, Kim KM3, Cho J4, Park SH1, Park YS1, Lim HY1, Yashiro M5, Kang WK1, Park JO6.

Oncotarget. 2014 Oct 15;5(19):9065-78.

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma

Hwang JA1¹, Yang HM2, Hong DP2, Joo SY3, Choi YL4, Park JH5, Lazar AJ6, Pollock RE7, Lev D6, Kim SJ8.

Genomics. 2014 Oct;104(4):234-41. doi: 10.1016/j.ygeno.2014.07.012. Epub 2014 Jul 25.

Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing

Xie T1¹, Cho YB2, Wang K3, Huang D4, Hong HK5, Choi YL6, Ko YH7, Nam DH8, Jin J9, Yang H10, Fernandez J11, Deng S12, Rejto PA13, Lee WY14, Mao M15.

Eur Spine J. 2014 Jan;23(1):27-31.

Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment

Kim J¹, Lee SH, Choi YL, Bae GE, Kim ES, Eoh W.

Br J Cancer. 2014 Jan 21;110(2):384-91. doi: 10.1038/bjc.2013.757. Epub 2013 Dec 17.

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

Park YH1¹, Jung HA1, Choi MK1, Chang W1, Choi YL2, Do IG2, Ahn JS1, Im YH1.

Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03627.

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling

Park S1¹, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL6.

J Clin Oncol. 2014 Jan 10;32(2):121-8. doi: 10.1200/JCO.2013.50.8556. Epub 2013 Dec 9.

Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

Kim Y1¹, Hammerman PS, Kim J, Yoon JA, Lee Y, Sun JM, Wilkerson MD, Pedamallu CS, Cibulskis K, Yoo YK, Lawrence MS, Stojanov P, Carter SL, McKenna A, Stewart C, Sivachenko AY, Oh IJ, Kim HK, Choi YS, Kim K, Shim YM, Kim KS, Song SY, Na KJ, Choi YL, Hayes DN, Kim J, Cho S, Kim YC, Ahn JS, Ahn MJ, Getz G, Meyerson M, Park K.

Breast Cancer Res. 2014 Sep 12;16(5):436. doi: 10.1186/s13058-014-0436-4.

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells

Bergamaschi A¹, Madak-Erdogan Z, Kim YJ, Choi YL, Lu H, Katzenellenbogen BS.

PLoS One. 2014 Aug 14;9(8):e99452. doi: 10.1371/journal.pone.0099452. eCollection 2014.

CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen

Lee S1¹, Park H1, Ha SY2, Paik KY3, Lee SE2, Kim JM1, Park JB1, Kwon CH1, Joh JW1, Choi YL4, Kim SJ5.

Int J Cancer. 2014 May 15;134(10):2424-36.

MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer

Kim YJ¹, Choi JS, Seo J, Song JY, Lee SE, Kwon MJ, Kwon MJ, Kundu J, Jung K, Oh E, Shin YK, Choi YL.

J Thorac Oncol. 2014 Apr;9(4):563-6. doi: 10.1097/JTO.0000000000000093.

A Novel Fusion of TPR and ALK in Lung Adenocarcinoma

Choi YL1¹, Lira ME, Hong M, Kim RN, Choi SJ, Song JY, Pandy K, Mann DL, Stahl JA, Peckham HE, Zheng Z, Han J, Mao M, Kim J.

J Thorac Oncol. 2014 Mar;9(3):419-22. doi: 10.1097/JTO.0000000000000061.

HIP1-ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma

Hong M1¹, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL.

J Mol Diagn. 2014 Mar;16(2):229-43. doi: 10.1016/j.jmoldx.2013.11.007. Epub 2014 Jan 10.

A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer

Lira ME1¹, Choi YL2, Lim SM3, Deng S1, Huang D1, Ozeck M1, Han J4, Jeong JY5, Shim HS5, Cho BC3, Kim J6, Ahn MJ7, Mao M8.

Anticancer Res. 2014 Feb;34(2):707-14.

Assessment of Intratumoral Heterogeneity of Oncogenic Driver Mutations in Surgically-resected Lung Adenocarcinoma: Implications of Percutaneous Biopsy-based Molecular Assay for Target-directed Therapy

Kim HK1¹, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J.

PLoS One. 2014 Feb 11;9(2):e88587. doi: 10.1371/journal.pone.0088587. eCollection 2014.

Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines

Yoon H1¹, Choi YL2, Song JY1, Do I3, Kang SY4, Ko YH5, Song S4, Kim BG6.

Urol Oncol. 2014 Jan;32(1):49.e23-31. doi: 10.1016/j.urolonc.2013.07.015.

FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy

Sung JY1¹, Sun JM2, Chang Jeong B3, Il Seo S3, Soo Jeon S3, Moo Lee H3, Yong Choi H3, Young Kang S4, Choi YL5, Young Kwon G6.

Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03623.

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling

Park S1¹, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL2.

Histol Histopathol. 2014 Jan;29(1):127-38. Epub 2013 Jul 15.

High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma

Lee SE1¹, Kim YJ2, Kwon MJ3, Choi DI4, Lee J5, Cho J1, Seo SW6, Kim SJ7, Shin YK8, Choi YL9.

Int J Gynecol Cancer. 2013 Nov;23(9):1552-60. doi: 10.1097/01.IGC.0000434105.98035.c7.

Establishment of Primary Xenograft Model From Newly Characterized Patient Extrauterine Carcinosarcoma

Lee HJ1¹, Choi HJ, Yang HM, Kim YM, Lee J, Chio D, Kim B, Choi YL, Kim SJ.

Pathol Int. 2013 Oct;63(10):502-5. doi: 10.1111/pin.12097. Epub 2013 Oct 18.

Epithelioid hemangioendothelioma with extensive cystic change and CAMTA1 rearrangement

Lee SE1¹, Park HY, Kim S, Bang H, Min JH, Choi YL.

PLoS One. 2013 Jul 29;8(7):e69752. doi: 10.1371/journal.pone.0069752. Print 2013.

Genetic Aberrations in Imatinib-Resistant Dermatofibrosarcoma Protuberans Revealed by Whole Genome Sequencing

Hong JY1¹, Liu X, Mao M, Li M, Choi DI, Kang SW, Lee J, La Choi Y.

Hum Pathol. 2013 Jul;44(7):1300-9. doi: 10.1016/j.humpath.2012.09.021. Epub 2013 Jan 22.

PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications

Ha SY1¹, Lee SE, Kwon MJ, Kim YJ, Lee EH, Seo J, Jang KT, Lee J, Choi YL.

Lung Cancer. 2013 Jul;81(1):109-16. doi: 10.1016/j.lungcan.2013.03.014. Epub 2013 Apr 6.

Prognostic significance of CD151 overexpression in non-small cell lung cancer

Kwon MJ1¹, Seo J, Kim YJ, Kwon MJ, Choi JY, Kim TE, Lee DH, Park S, Shin YK, Han J, Choi YL.

J Clin Oncol. 2013 Mar 20;31(9):e132-6. doi: 10.1200/JCO.2012.44.0800. Epub 2013 Jan 28.

Angiosarcoma Arising Within a Long-Standing Cystic Lesion of the Adrenal Gland: A Case Report

Sung JY1¹, Ahn S, Kim SJ, Park YS, Choi YL.

PLoS One. 2013;8(2):e56011. doi: 10.1371/journal.pone.0056011. Epub 2013 Feb 28.

EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital

Choi YL1¹, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM.

Korean J Pathol. 2013 Feb;47(1):77-81. doi: 10.4132/KoreanJPathol.2013.47.1.77. Epub 2013 Feb 25.

Peripheral Primitive Neuroectodermal Tumor with Osseous Component of the Small Bowel Mesentery: A Case Study

Kim JM1¹, Chu YC, Choi CH, Kim L, Choi SJ, Park IS, Han JY, Kim KR, Choi YL, Kim T.

Lung Cancer. 2013 Jan;79(1):40-5. doi: 10.1016/j.lungcan.2012.10.002. Epub 2012 Oct 25.

Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer

Lee HY1¹, Ahn HK, Jeong JY, Kwon MJ, Han JH, Sun JM, Ahn JS, Park K, Choi YL, Ahn MJ.

J Mol Diagn. 2013 Jan;15(1):51-61. doi: 10.1016/j.jmoldx.2012.08.006. Epub 2012 Dec 12.

Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer

Lira ME1¹, Kim TM, Huang D, Deng S, Koh Y, Jang B, Go H, Lee SH, Chung DH, Kim WH, Schoenmakers EF, Choi YL, Park K, Ahn JS, Sun JM, Ahn MJ, Kim DW, Mao M.

Int J Oncol. 2012 Dec;41(6):2013-20. doi: 10.3892/ijo.2012.1663. Epub 2012 Oct 15.

Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer

Lee HW1¹, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH.

Korean J Pathol. 2012 Oct;46(5):436-42. doi: 10.4132/KoreanJPathol.2012.46.5.436. Epub 2012 Oct 25.

A Proposal for Creating a Guideline for Cancer Registration of the Fibromatosis, PEComa Group, Malignant Lymphoma In Situ and Dendritic Cell Tumors (III)

Yoo C1¹, Kang CS, Choi YL, Kang HY, Kim JM, Koh YH, Lee JH, Lee SS, Kim IS, Kim DH, Park YK, Sohn JH.

Int J Oncol. 2012 Sep;41(3):839-48. doi: 10.3892/ijo.2012.1517. Epub 2012 Jun 12.

Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting beta-catenin signaling

Kundu J1¹, Wahab SM, Kundu JK, Choi YL, Erkin OC, Lee HS, Park SG, Shin YK.

Hum Pathol. 2012 Aug;43(8):1234-42. doi: 10.1016/j.humpath.2011.09.012. Epub 2012 Jan 14.

The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases

Lee SE1¹, Lee EH, Park H, Sung JY, Lee HW, Kang SY, Seo S, Kim BH, Lee H, Seo AN, Ahn G, Choi YL.

Korean J Pathol. 2012 Jun;46(3):306-10. doi: 10.4132/KoreanJPathol.2012.46.3.306. Epub 2012 Jun 22.

Extranodal Follicular Dendritic Cell Sarcoma with Rapid Growth in Parapharynx: A Case Report

Pyo JS1¹, Kang G, Do SI, Chae SW, Kim K, Lee SH, Choi YL, Choi JH, Sohn JH, Kim DH.

Brain Pathol. 2012 May;22(3):307-17. doi: 10.1111/j.1750-3639.2011.00532.x. Epub 2011 Nov 14.

Mutated IDH1 Is a Favorable Prognostic Factor for Type 2 Gliomatosis Cerebri

Kwon MJ1¹, Kim ST, Kwon MJ, Kong DS, Lee D, Park S, Kang SY, Song JY, Nam DH, Kato Y, Choi YL, Suh YL.

Breast Cancer Res Treat. 2012 Apr;132(2):499-509. doi: 10.1007/s10549-011-1626-8. Epub 2011 Jun 11.

A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity

Oh E1¹, Choi YL, Park T, Lee S, Nam SJ, Shin YK.

Korean J Pathol. 2012 Apr;46(2):115-22. doi: 10.4132/KoreanJPathol.2012.46.2.115. Epub 2012 Apr 25.

Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience

Cho J1¹, Lee SE, Choi YL.

Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8.

The synergistic therapeutic effect of cisplatin with Human Papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo

Jung HS1¹, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.

Histol Histopathol. 2012 Feb;27(2):197-207.

High MET copy number and MET overexpression: Poor outcome in non-small cell lung cancer patients

Park S1¹, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J.

Br J Cancer. 2012 Feb 28;106(5):923-30. doi: 10.1038/bjc.2012.11. Epub 2012 Jan 31.

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

Kwon MJ1¹, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL.

Pain Physician. 2012 Jan-Feb;15(1):E107-13.

The Neurological Safety of Intrathecal Acyclovir in Rats

Kim H1¹, Choi YL, Lee DK, Choi SS, Lee IO, Kong MH, Kim NS, Lim SH, Lee M.

Histopathology. 2012 Jan;60(2):347-56. doi: 10.1111/j.1365-2559.2011.04072.x.

Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast

Kim T1¹, Jung EA, Song JY, Roh JH, Choi JS, Kwon JE, Kang SY, Cho EY, Shin JH, Nam SJ, Yang JH, Choi YL.

Pathol Int. 2012 Jan;62(1):65-8. doi: 10.1111/j.1440-1827.2011.02752.x. Epub 2011 Nov 24.

Sclerosing epithelioid fibrosarcoma: Cytogenetic analysis of FUS rearrangement

Yoon N1¹, Kwon JW, Seo SW, Ahn G, Choi YL.

Pathol Res Pract. 2011 Dec 15;207(12):762-8. doi: 10.1016/j.prp.2011.10.002. Epub 2011 Nov 8.

Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue

Kwon MJ1¹, Lee SE, Kang SY, Choi YL.

Pathol Res Pract. 2011 Oct 15;207(10):634-9. doi: 10.1016/j.prp.2011.07.011. Epub 2011 Sep 21.

Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors

Kwon MJ1¹, Choi YL, Sung KW, Kang SY, Park SM, Choi SY, Kim JS, Suh YL.

Histol Histopathol. 2011 Oct;26(10):1231-41.

Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry

Jung HS1¹, Choi YL, Choi JS, Roh JH, Pyon JK, Woo KJ, Lee EH, Jang KT, Han J, Park CS, Park YS, Shin YK.

Cancer Chemother Pharmacol. 2011 Sep;68(3):743-51. doi: 10.1007/s00280-010-1545-0. Epub 2010 Dec 18.

Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

Lee SJ1¹, Choi YL, Park YH, Kim ST, Cho EY, Ahn JS, Im YH.

Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Manifested as a Soft Tissue Mass: Incidental Discovery on Histological Examination

PLoS Genet. 2011 Mar;7(3):e1001351. doi: 10.1371/journal.pgen.1001351. Epub 2011 Mar 31.

Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis

Choi JW1¹, Kim DG, Lee AE, Kim HR, Lee JY, Kwon NH, Shin YK, Hwang SK, Chang SH, Cho MH, Choi YL, Kim J, Oh SH, Kim B, Kim SY, Jeon HS, Park JY, Kang HP, Park BJ, Han JM, Kim S.

PLoS One. 2011 Feb 24;6(2):e16636. doi: 10.1371/journal.pone.0016636.

Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker

Lin AY1¹, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR.

Tumour Biol. 2011 Feb;32(1):45-51. doi: 10.1007/s13277-010-0089-6. Epub 2010 Aug 10.

Clinical presentation of carcinoma of unknown primary: 14 years of experience

Yi JH1¹, La Choi Y, Lee SJ, Ahn HK, Baek KK, Lim T, Lee DJ, Han BR, Lee HY, Jun HJ, Lee J, Park YH.

Exp Mol Med. 2011 Feb 28;43(2):91-100.

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration

Park K1¹, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH.

BMC Cancer. 2010 Sep 23;10:507. doi: 10.1186/1471-2407-10-507.

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival (vol 10, pg 507, 2010)

Choi YL1¹, Oh E, Park S, Kim Y, Park YH, Song K, Cho EY, Hong YC, Choi JS, Lee JE, Kim JH, Nam SJ, Im YH, Yang JH, Shin YK.

J Plast Reconstr Aesthet Surg. 2010 Dec;63(12):2064-70. doi: 10.1016/j.bjps.2010.01.020. Epub 2010 Mar 5.

Merkel cell carcinoma: Our experience with seven patients in Korea and a literature review

Woo KJ1¹, Choi YL, Jung HS, Jung G, Shin YK, Jang KT, Han J, Pyon JK.

Virchows Arch. 2009 Feb;454(2):203-10. doi: 10.1007/s00428-008-0703-9. Epub 2008 Dec 20.

One-step Nucleic Acid Amplification (OSNA): Intraoperative Rapid Molecular Diagnostic Method for the Detection of Sentinel Lymph Node Metastases in Breast Cancer Patients in Korean Cohort

Schem C1¹, Maass N, Bauerschlag DO, Carstensen MH, Loning T, Roder C, Batic O, Jonat W, Tiemann K.

Pathol Int. 2010 Dec;60(12):784-6. doi: 10.1111/j.1440-1827.2010.02599.x. Epub 2010 Sep 24.

Dermatofibrosarcoma protuberans of the breast skin

Kim T1¹, Choi YL, Park HY, Song JY, Shin JH, Nam SJ, Ahn G.

BMC Cancer. 2010 Sep 23;10:507. doi: 10.1186/1471-2407-10-507.

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

Choi YL1¹, Oh E, Park S, Kim Y, Park YH, Song K, Cho EY, Hong YC, Choi JS, Lee JE, Kim JH, Nam SJ, Im YH, Yang JH, Shin YK.

Carcinogenesis. 2010 Jun;31(6):974-83. doi: 10.1093/carcin/bgp336. Epub 2010 Jan 6.

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications

Kwon MJ1¹, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK.

The Frequency of BRAF Mutation in Very Small Papillary Thyroid Carcinomas

Med Oncol.?2010 Jun;27(2):459-65. doi: 10.1007/s12032-009-9234-8. Epub 2009 May 27.

Expression of MET in alveolar soft part sarcoma

Jun HJ1¹,?Lee J,?Lim do H,?Park JO,?Ahn G,?Seo SW,?Sung KS,?Lim do H,?Yoo KH,?Choi YL.

Cancer Res. 2010 Mar 15;70(6):2296-306. doi: 10.1158/0008-5472.CAN-09-3141. Epub 2010 Mar 9.

LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer

Choi YL1¹, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR.

Histopathology. 2010 Feb;56(3):408-10. doi: 10.1111/j.1365-2559.2010.03487.x.

FOXL2 mutation in granulosa-cell tumours of the ovary

Kim T¹, Sung CO, Song SY, Bae DS, Choi YL.

Int J Gynecol Pathol. 2009 Nov;28(6):529-34. doi: 10.1097/PGP.0b013e3181a2b8d3.

Atypical Leiomyomas of the Uterus With Long-term Follow-up After Myomectomy With Immunohistochemical Analysis for p16(INK4A), p53, Ki-67, Estrogen Receptors, and Progesterone Receptors

Sung CO1¹, Ahn G, Song SY, Choi YL, Bae DS.

Hepatology. 2009 Apr;49(4):1122-31. doi: 10.1002/hep.22740.

Liver X Receptor Mediates Hepatitis B Virus X Protein-Induced Lipogenesis in Hepatitis B Virus-Associated Hepatocellular Carcinoma

Na TY1¹, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee MO.

Breast Cancer Res Treat. 2009 Jan;113(1):83-93. doi: 10.1007/s10549-008-9909-4. Epub 2008 Jan 29.

Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients

Choi YJ1¹, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ.

Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004. Epub 2008 Oct 2.

CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer

Bergamaschi A1¹, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langer��d A, Han W, Noh DY, Huntsman DG, Jeffrey SS, B��rresen-Dale AL, Pollack JR.

Prostate. 2008 Aug 1;68(11):1248-56. doi: 10.1002/pros.20792.

Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle

Thompson M1¹, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR.

Cancer Res. 2008 Aug 15;68(16):6831-9. doi: 10.1158/0008-5472.CAN-07-6195.

Centrosomal PKC beta II and pericentrin are critical for human prostate cancer growth and angiogenesis

Kim J1¹, Choi YL, Vallentin A, Hunrichs BS, Hellerstein MK, Peehl DM, Mochly-Rosen D.

Oncogene. 2008 Jun 5;27(25):3635-40. doi: 10.1038/sj.onc.1211012. Epub 2008 Jan 21.

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Kwei KA1¹, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, Lee J, Choi YL, Sato M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR.

PLoS Genet. 2008 May 23;4(5):e1000081. doi: 10.1371/journal.pgen.1000081.

Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer

Kwei KA1¹, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, van de Rijn M, Maitra A, Pollack JR.

Histol Histopathol. 2007 Nov;22(11):1185-95.

Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation

Choi YL1¹, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.

Clin Cancer Res. 2007 May 1;13(9):2584-91.

Clinical significance of CD99 down-regulation in gastric adenocarcinoma

Lee JH1¹, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK.

Histol Histopathol. 2007 Mar;22(3):227-34.

Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease

Xuan YH1¹, Choi YL, Shin YK, Ahn GH, Kim KH, Kim WJ, Lee HC, Kim SH.

Arch Pathol Lab Med. 2007 Feb;131(2):275-81.

Overexpression of CD24 - Association with invasiveness in urothelial carcinoma of the bladder

Choi YL1¹, Lee SH, Kwon GY, Park CK, Han JJ, Choi JS, Choi HY, Kim SH, Shin YK.

Clin Cancer Res. 2007 Jan 1;13(1):102-10.

Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression

Wang LH1¹, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, Hong YC, Wu CF, Shin YK.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53.

Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis

Lee SJ1¹, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH.

Tumour Biol. 2007;28(6):327-32. doi: 10.1159/000124238. Epub 2008 Apr 4.

Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women

Choi YL1¹, Cho EY, Kim JH, Nam SJ, Oh YL, Song SY, Yang JH, Kim DS.

Mod Pathol. 2006 Aug;19(8):1139-47. Epub 2006 Jun 16.

Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions

Xuan YH1¹, Jung HS, Choi YL, Shin YK, Kim HJ, Kim KH, Kim WJ, Lee YJ, Kim SH.

Jpn J Clin Oncol. 2006 Aug;36(8):489-93. Epub 2006 Jun 20.

Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer

Choi YJ1¹, Yun HR, Yoo KE, Kim JH, Nam SJ, Choi YL, Ko YH, Kim BT, Yang JH.

J Korean Med Sci. 2006 Jun;21(3):559-62.

Gastric syphilis mimicking adenocarcinoma : A case report

Choi YL1¹, Han JJ, Lee da K, Cho MH, Kwon GY, Ko YH, Park CK, Ahn G.

Mod Pathol. 2006 May;19(5):675-83.

Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions

Wang LH1¹, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, Yun HY, Park SM, Kim WJ, Kim HJ, Choi JS, Kim SH.

Virchows Arch. 2006 Mar;448(3):331-6. Epub 2005 Nov 29.

Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas

Choi YL1¹, Kang SY, Shin YK, Choi JS, Kim SH, Lee SJ, Bae DS, Ahn G.

Clin Neuropathol. 2006 Jan-Feb;25(1):29-36.

Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy

Choi YL1¹, Suh YL, Kim D, Ko YH, Sung CO, Lee JI.

Anesth Analg. 2005 Nov;101(5):1422-6.

The neurological safety of epidural gabapentin in rats: A light microscopic examination

Choi SS1¹, Kim YC, Lim YJ, Lee CJ, Lee PB, Lee SC, Sim WS, Choi YL.

J Korean Med Sci. 2005 Oct;20(5):853-9.

Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas

Choi YL1¹, Kim MK, Suh JW, Han J, Kim JH, Yang JH, Nam SJ.

Gynecol Oncol. 2005 May;97(2):379-86.

Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors

Choi YL1¹, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G.

J Neurooncol. 2005 May;73(1):19-27.

HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors

Choi YL1¹, Kim CJ, Matsuo T, Gaetano C, Falconi R, Suh YL, Kim SH, Shin YK, Park SH, Chi JG, Thiele CJ.

Histol Histopathol. 2005 Jan;20(1):59-66.

An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions

Xuan YH1¹, Choi YL, Shin YK, Kook MC, Chae SW, Park SM, Chae HB, Kim SH.

Epilepsy Res. 2004 Dec;62(2-3):171-8.

Cortical laminar disorganization is correlated with severity of the cortical dysplasia and surgical outcome - experience with 150 cases

Choi YL1¹, Park SH, Chung CK, Suh YL, Chi JG.

J Histochem Cytochem. 2004 May;52(5):591-601.

An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions

Choi YL1¹, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW, Kim SH.

Anesth Analg. 2003 Dec;97(6):1716-20.

The neurotoxicity of epidural hyaluronic acid in rabbits: A light and electron microscopic examination

Lim YJ1¹, Sim WS, Kim YC, Lee SC, Choi YL.

Am J Surg Pathol. 2003 Jul;27(7):919-28.

Primary central nervous system lymphoma in Korea - Comparison of B- and T-cell lymphomas

Choi JS1¹, Nam DH, Ko YH, Seo JW, Choi YL, Suh YL, Ree HJ.

FEBS Lett. 2003 Apr 10;540(1-3):217-22.

Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton

Yoon SS1¹, Jung KI, Choi YL, Choi EY, Lee IS, Park SH, Kim TJ.

Exp Mol Med. 2002 Dec 31;34(6):411-8.

Characterization and epitope mapping of two monoclonal antibodies against human CD99

Gil MC1¹, Lee MH, Seo JI, Choi YL, Kim MK, Jung KC, Park SH, Kim TJ.

Pathol Int. 2002 May-Jun;52(5-6):358-66.

Comparative study of non-functional islet cell tumors and pancreatic solid and papillary neoplasms: Biological behavior and immunohistochemistry

Choi YL1¹, Oh YL, Kim SH, Park CK, Ahn G.

J Korean Med Sci. 2001 Aug;16(4):424-32.

Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: Association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma

Choi YL1¹, Park SH, Jang JJ, Park CK.

Appl Immunohistochem Mol Morphol. 2001 Jun;9(2):125-9.

CD99 immunoreactivity in ependymoma

Choi YL1¹, Chi JG, Suh YL.

Diagn Cytopathol. 2001 Apr;24(4):256-9.

Cytologic clue of so-called nodular histiocytic hyperplasia of the pleura

Choi YL1¹, Song SY.

Arch Pathol Lab Med. 2000 Apr;124(4):563-9.

Immunoexpression of inhibin alpha subunit, inhibin/activin beta A subunit and CD99 in ovarian tumors

Choi YL1¹, Kim HS, Ahn G.